Hayden Royal »

Vertex Pharmaceuticals Incorporated shares owned by Hayden Royal

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Hayden Royal from 13F filings

Historical chart of Hayden Royal investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Hayden Royal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Hayden Royal

Quarter filed Position value Share count Share price at filing
2021-12-31 $233k 1.1k 219.81
2021-09-30 $214k 1.2k 181.20
2021-06-30 $206k 1.0k 201.37
2021-03-31 $213k 992 214.72
2020-06-30 $1.4M 4.9k 290.31

More positions owned by Hayden Royal

iShares S&P 500 Growth Exchange Traded Fund (IVW)
iShares S&P 500 Value Exchange Traded Fund (IVE)
Spdr S&p 500 Etf Exchange Traded Fund (SPY)
iShares S&P Small-Cap 600 Growth ETF Exchange Traded Fund (IJT)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc A Common Stock (GOOGL)
iShares S&P Small-Cap 600 Value ETF Exchange Traded Fund (IJS)
Amazon.com Common Stock (AMZN)
iShares US Treasury Bond Exchange Traded Fund (GOVT)
iShares Core S&P 500 Exchange Traded Fund (IVV)
ARK Innovation ETF Exchange Traded Fund (ARKK)
Rapid7 Common Stock (RPD)
AbbVie Common Stock (ABBV)
Regeneron Pharmaceuticals Common Stock (REGN)

View all positions for Hayden Royal

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated